The term LOC644297 Inhibitors delineates a specific class of chemical compounds strategically designed to modulate the activity of LOC644297, a molecular target currently under scientific scrutiny. These inhibitors are meticulously crafted through principles rooted in medicinal chemistry, with a primary focus on selectively interfering with the normal functions of LOC644297 within cellular processes. The structural features of LOC644297 Inhibitors undergo a rigorous optimization process, often involving computational modeling and structure-activity relationship studies, to ensure their molecular configurations are finely tuned for precise binding to the target.
The significance of LOC644297 Inhibitors lies in their potential to disrupt the biochemical activities associated with LOC644297, a molecular entity believed to play a role in various biological pathways. Researchers in this field delve into the three-dimensional structure of LOC644297 and its binding interactions with inhibitors, aiming to unravel the intricate molecular mechanisms underlying inhibition. The study of LOC644297 Inhibitors contributes to a broader understanding of cellular processes, offering insights into the roles played by LOC644297 in diverse biological pathways and expanding our knowledge of the regulatory networks governing cellular activities. This research not only advances our comprehension of the molecular intricacies surrounding LOC644297 but also contributes to the broader scientific understanding of molecular targets and their involvement in fundamental cellular functions.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
These compounds can alter chromatin structure and gene expression, potentially reducing FAM215B transcription. | ||||||
5-Bromo-2′-deoxyuridine | 59-14-3 | sc-290815 sc-290815A sc-290815B sc-290815C sc-290815D | 50 mg 250 mg 500 mg 1 g 5 g | $50.00 $79.00 $85.00 $129.00 $601.00 | ||
These prevent mRNA synthesis, which could lead to reduced expression of many proteins, including FAM215B. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitors can downregulate protein synthesis at a global level, potentially decreasing FAM215B expression. | ||||||
SU6656 | 330161-87-0 | sc-203286 sc-203286A | 1 mg 5 mg | $57.00 $133.00 | 27 | |
These compounds inhibit the PI3K/Akt/mTOR pathway, which is often involved in the control of cell growth and gene expression. | ||||||
Topotecan | 123948-87-8 | sc-338718 | 100 mg | $582.00 | ||
These inhibitors prevent the relaxation of supercoiled DNA, potentially affecting transcription and subsequent protein expression. | ||||||